A bill for an act relating to abortions including informed consent, dispensing abortion-inducing drugs, and reporting abortion-inducing drug complications.

This bill establishes new requirements for physicians performing abortions in Iowa, specifically targeting chemical abortions using drugs like mifepristone or misoprostol. It mandates that physicians obtain a patient's signature on a U.S. FDA form, provide written confirmation about specific risks (including hemorrhage, incomplete abortion, and potential reversal), and advise on emergency surgical options before dispensing abortion-inducing drugs. The bill also requires the state health department to publish online information about reversing chemical abortions and defines "abortion-inducing drug complications" to include issues like infection or retained tissue. These provisions directly affect physicians who perform abortions and pregnant women seeking chemical abortion services.